Published on 31 October 2024

Webinar on the OECD Report

The Organisation for Economic Cooperation and Development (OECD) published a new study (Embracing a One Health Framework to Fight Antimicrobial Resistance), which highlights the cost efficiency of measures to prevent and control antimicrobial resistance (AMR). For Switzerland it projects annual costs of up to CHF 750 million by 2050. The study estimates that for every Swiss franc invested in a package of measures to tackle AMR, around CHF 6 in health costs can be saved.